Year: 2015
Type: article
Abstract: Estimates of life expectancy are of obvious importance to people with HIV-1, and are essential to monitor and predict the progress of the HIV/AIDS epidemic and to plan health services. The Rwandan study reported by Sabin Nsanzimana and colleagues1 in The Lancet Global Health is the first from sub-Saharan Africa to focus on the evolution of HIV-positive life expectancy during the scale-up of antiretroviral therapy, and is a welcome addition to a small body of data. The investigators show that the scale-up of antiretroviral therapy resulted in substantial gains in life expectancy, with near-normal life expectancy in individuals enrolled in care with little immunodeficiency.
Source: The Lancet Global Health
Authors: Matthias Egger, Leigh F Johnson
Institutions: University of Bern, University of Cape Town
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $6,680
OpenAlex ID: W2164333479